These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23241075)

  • 21. Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers.
    Farhat GN; Cummings SR; Chlebowski RT; Parimi N; Cauley JA; Rohan TE; Huang AJ; Vitolins M; Hubbell FA; Manson JE; Cochrane BB; Lane DS; Lee JS
    J Natl Cancer Inst; 2011 Apr; 103(7):562-70. PubMed ID: 21330633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers.
    Park S; Koo JS; Kim MS; Park HS; Lee JS; Lee JS; Kim SI; Park BW; Lee KS
    Ann Oncol; 2011 Aug; 22(8):1755-62. PubMed ID: 21310761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
    Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
    Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen receptor and metastasis-associated protein-1 are frequently expressed in estrogen receptor negative/HER2 positive breast cancer.
    Zhao L; Niu F; Shen H; Liu X; Chen L; Niu Y
    Virchows Arch; 2016 Jun; 468(6):687-96. PubMed ID: 27026268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers.
    Micello D; Marando A; Sahnane N; Riva C; Capella C; Sessa F
    Virchows Arch; 2010 Oct; 457(4):467-76. PubMed ID: 20809337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of endocrine therapy on the ratio of androgen receptor (AR) to estrogen receptor (ER) positive circulating epithelial tumor cells (CETCs) in breast cancer.
    Pizon M; Lux D; Pachmann U; Pachmann K; Schott D
    J Transl Med; 2018 Dec; 16(1):356. PubMed ID: 30547831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of androgen receptor in breast cancer & its correlation with other steroid receptors & growth factors.
    Mishra AK; Agrawal U; Negi S; Bansal A; Mohil R; Chintamani C; Bhatnagar A; Bhatnagar D; Saxena S
    Indian J Med Res; 2012 Jun; 135(6):843-52. PubMed ID: 22825604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Androgen Receptor in Estrogen Receptor-positive Breast Cancer.
    Agrawal A; Ziolkowski P; Grzebieniak Z; Jelen M; Bobinski P; Agrawal S
    Appl Immunohistochem Mol Morphol; 2016 Sep; 24(8):550-5. PubMed ID: 26230371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies.
    Venema CM; Mammatas LH; Schröder CP; van Kruchten M; Apollonio G; Glaudemans AWJM; Bongaerts AHH; Hoekstra OS; Verheul HMW; Boven E; van der Vegt B; de Vries EFJ; de Vries EGE; Boellaard R; Menke van der Houven van Oordt CW; Hospers GAP
    J Nucl Med; 2017 Dec; 58(12):1906-1912. PubMed ID: 28912144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution and characteristics of androgen receptor (AR) in breast cancer among women in Addis Ababa, Ethiopia: A cross sectional study.
    Hadgu E; Seifu D; Tigneh W; Bokretsion Y; Bekele A; Abebe M; Sollie T; Karlsson C; Karlsson MG
    PLoS One; 2020; 15(5):e0232519. PubMed ID: 32374753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgen receptor CAG repeat length and estrogen receptor status in postmenopausal breast cancer prognosis.
    Cogliati P; Ciniselli CM; Agresti R; Paolini B; Bonini C; Radice P; Krogh V; Verderio P; Venturelli E
    Int J Biol Markers; 2015 Nov; 30(4):e418-24. PubMed ID: 26541420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A SOX10+/AR- immunoprofile may identify a subset of low positive ER carcinomas with a wider range of ER expression.
    Keske A; Shetty S; Weisman P; Yu Q; McGregor SM; Xu J
    Pathol Res Pract; 2023 Aug; 248():154628. PubMed ID: 37399589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen Receptor Expression and Breast Cancer Survival: Results From the Nurses' Health Studies.
    Kensler KH; Poole EM; Heng YJ; Collins LC; Glass B; Beck AH; Hazra A; Rosner BA; Eliassen AH; Hankinson SE; Winer EP; Brown M; Tamimi RM
    J Natl Cancer Inst; 2019 Jul; 111(7):700-708. PubMed ID: 30445651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations.
    Agoff SN; Swanson PE; Linden H; Hawes SE; Lawton TJ
    Am J Clin Pathol; 2003 Nov; 120(5):725-31. PubMed ID: 14608899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of testosterone and estrogen treatment on the distribution of sex hormone receptors in the endometrium of postmenopausal women.
    Zang H; Sahlin L; Masironi B; Hirschberg AL
    Menopause; 2008; 15(2):233-9. PubMed ID: 18030175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study.
    Jinna ND; Van Alsten S; Rida P; Seewaldt VL; Troester MA
    Breast Cancer Res Treat; 2023 Sep; 201(2):171-181. PubMed ID: 37438515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?
    Bronte G; Rocca A; Ravaioli S; Puccetti M; Tumedei MM; Scarpi E; Andreis D; Maltoni R; Sarti S; Cecconetto L; Fedeli A; Pietri E; De Simone V; Asioli S; Amadori D; Bravaccini S
    BMC Cancer; 2018 Mar; 18(1):348. PubMed ID: 29587674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgen receptor expression and breast cancer mortality in a population-based prospective cohort.
    Elebro K; Bendahl PO; Jernström H; Borgquist S
    Breast Cancer Res Treat; 2017 Oct; 165(3):645-657. PubMed ID: 28643022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer.
    Pietri E; Massa I; Bravaccini S; Ravaioli S; Tumedei MM; Petracci E; Donati C; Schirone A; Piacentini F; Gianni L; Nicolini M; Campadelli E; Gennari A; Saba A; Campi B; Valmorri L; Andreis D; Fabbri F; Amadori D; Rocca A
    Oncologist; 2019 Jun; 24(6):743-e205. PubMed ID: 30591548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.